Pfizer Chairman and Chief Executive Officer Dr. Albert Bourla said the ongoing clinical trial for a COVID-19 vaccine has enrolled about 23,000 participants, and some are already getting the second dose of the vaccine.
Pfizer “should be able to have enough events to say, if the product works or not” by the end of October, Bourla said, speaking on Thursday to the International Federation of Pharmaceutical Manufacturers and Associations.
“We have already worked on the rest of the file,” he said, meaning if the vaccine is effective, “we are going to start submitting to the FDA, on a rolling base.” Bourla said if they are able to determine the vaccine is safe and effective “in the October time frame,” the company could “submit immediately for approval.”
Pfizer is in the “very advanced stage” of the clinical trial, Bourla said, confirming that as of yesterday, 23,000 patients were enrolled into the study. Pfizer is aiming to enroll 30,000 patients in the Phase 3 trial.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Senators raise possible PhilHealth hospital fund depletion in COVID-19 lab spendingA number of senators on Wednesday said the proposal to use funds from the Philippine Health Insurance Corporation to build more COVID-19 testing laboratories might be to the detriment of coronavirus patients.
Read more »
‘FDA approval needed for COVID-19 vaccine trials,’ DOH reminds Cavite prov’l gov’t - Manila BulletinThe Department of Health (DOH) reminded the provincial government of Cavite that they need to secure the approval of the Food and Drug Administration (FDA) before they could start their planned participation in COVID-19 vaccine clinical trials.
Read more »
Rape-slay convict Sanchez 'a probable COVID-19 patient': BuCor
Read more »
New COVID-19 study reveals more about possible risks to pregnant womenPregnant women who are diagnosed with COVID-19 in the hospital appear to be less likely to have symptoms of fever and muscle pain but more likely to be admitted to the ICU, new study says.
Read more »
Ilang bahagi ng 2 ospital sa Antipolo, isinara dahil sa COVID-19
Read more »
Telco provider introduces new hotline platform for COVID-19 questions, concernsA telecommunication provider launched a new platform to provide local government units an additional communication channel for novel coronavirus concerns. The Project Hotline platform is a wireless solution package that Smart-PLDT could help residents, local officials and frontline responders report infections and address related problems amid the pandemic. “Project Hotline is part of our efforts to …
Read more »